Skip to Content


In the US, Levetiracetam (levetiracetam systemic) is a member of the drug class pyrrolidine anticonvulsants and is used to treat Bipolar Disorder, Epilepsy, Hyperekplexia, Neuralgia, New Daily Persistent Headache and Seizures.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiepileptic agent

Pyrrolidone derivative

Chemical Names

(S)-alpha-Etyl-2-oxo-1-pyrrolidineacetamide (WHO)

1-Pyrrolidineacetamide, alpha-etyl-2-oxo-, (S)-

Foreign Names

  • Levetiracetamum (Latin)
  • Levetiracetam (German)
  • Lévétiracétam (French)
  • Levetiracetam (Spanish)

Generic Names

  • Levetiracetam (OS: USAN, BAN, JAN)
  • Lévétiracétam (OS: DCF)
  • Levetiracetam (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Lévétiracétam (PH: Ph. Eur. 8)
  • Levetiracetamum (PH: Ph. Eur. 8)

Brand Names


BANBritish Approved Name
DCFDénomination Commune Française
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.